chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 days after the 1st shot, I got extreme hives all over my face and chest.  Internal medicine Dr prescribed a steroid to take an hour before I took the 2nd shot - as a precaution.  On the 9th day after the 1st shot, I felt like I had food poisoning.  Abdominal cramps.  Vomitting.  diarrhea.  Started getting really cold in my extremities and nose, but didn't really think much of it.  Had to take 2 days off from work to recover.  Took the steroid, got my 2nd shot.  Ended up having hives 2 days later, but not as bad.  9 days later, I ended up having extreme abdominal cramps, Vomitting, diarrhea, and I nearly passed out at work.  EMTs called.  BP extremely low.  BPM were in the upper 30's.  Taken to ER.  Given 2 bags of fluids.  BP came back up to a low level.  BPM never came out of the 40s.     Since then, I've been monitoring my BPM.  My extremities get really cold to the touch, including my nose, and it is common for my BPM to go into the mid 30s to 40s.  Getting the BPM to get into the 60s takes excessive moving / working out.  Nose is nearly always cold.    Fatigued easily.
Immunocompromised patient did not receive his third full dose in his primary series.; Immunocompromised patient did not receive his third full dose in his primary series. Patient did receive his booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Immunocompromised patient did not receive his third full dose in his primary series.) and INCORRECT DOSE ADMINISTERED (Immunocompromised patient did not receive his third full dose in his primary series. Patient did receive his booster dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised (The patient was immunocompromised).    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Immunocompromised patient did not receive his third full dose in his primary series.) and INCORRECT DOSE ADMINISTERED (Immunocompromised patient did not receive his third full dose in his primary series. Patient did receive his booster dose). At the time of the report, ACCIDENTAL UNDERDOSE (Immunocompromised patient did not receive his third full dose in his primary series.) and INCORRECT DOSE ADMINISTERED (Immunocompromised patient did not receive his third full dose in his primary series. Patient did receive his booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient received primary Moderna Covid-19 vaccination series.  No treatment details were reported.
Per Moderna Vaccine Manufacturer,  "The maximum number of doses extracted from either vial presentation should not exceed 20 doses." 21 doses were extracted from one vial. At approximately 1715,vial stopper was cleaned with new alcohol prep pad and 0.25 ML of Moderna Covid-19 Vaccine was extracted from vial, exceeding 20 doses extracted from vial. At 1719, pt. was injected in right deltoid.  Pt. was monitored closely for 15 mins. after vaccine was given. Pt. tolerated vaccine and no adverse reactions noted.
P/a first dose given 15JUN90, pt experienced diarrhea & recovered 16JUN90; Received 2nd dose JUL90 & on 24JUL90 onset of chest pain, nausea, malaise, felt weak; Recovered 27JUL90 p/3days bedrest;
Pt exp generalized fine rash, edema-face, fingers, & h/a; no treatment; rxn started on 9APR91 aobut 11AM & began resolving 11APR91 PM:
Metal taste in mouth within 5 minutes of 3rd shot (date above) and 2nd Pfizer shot (03/28/2021) - disappeared in 2 hours both times. Ear Tinnitus - noticeable within a few days of 3rd shot (date above). - continues today - no improvement. loud in the quiet - disappears with daily living noises
No adverse event directly related to the vaccine was experienced, in my opinion.  I had a pre-existing illness that I thought had cleared up and then developed a secondary infection after I received the vaccine.  After the vaccine, I experienced only mild soreness at the vaccine site and fatigue for approximately 24 hours.
This spontaneous report as received from a nurse refers to a 59 years old patient. The patient was vaccinated with a dose of VARIVAX (Merck) on 02-NOV-2012 (lot number, dose and route not provided). No other co-suspects were reported. No concomitant mediations were reported. On 02-NOV-2012 the patient received VARIVAX (Merck) instead of ZOSTAVAX due to human error. No adverse event was reported. Additional information has been requested.
not comfortable; rash from injection site; swelling from injection site; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (not comfortable), VACCINATION SITE RASH (rash from injection site) and VACCINATION SITE SWELLING (swelling from injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced DISCOMFORT (not comfortable), VACCINATION SITE RASH (rash from injection site) and VACCINATION SITE SWELLING (swelling from injection site). At the time of the report, DISCOMFORT (not comfortable), VACCINATION SITE RASH (rash from injection site) and VACCINATION SITE SWELLING (swelling from injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up was received on 26 may 2021 included  non-Significant Fu: Outcome of events was recovered and reporter denied further follow up.
3RD DOSE OF COVID VACCINE, PFIZER GIVEN 9/13/21, LOT #FE3592; pt had a recent hospitalization for Adult Failure to Thrive; family unable to care for him at home; was dc'd to Health Care for rehabilitation and strengthening; while in SNF pt tested positive for COVID on 7/30/22; pt did well and did not have any SOB; on 8/4/22 pt was found unresponsive requiring CPR; pt did not respond and passed away in the rehab facility
Patient was given 1 full vial that was not diluted. Patient received all 3 doses contained within in the vial. No adverse events reported at this time
1/15 starting with burning tingling hands that become itchy and tingling, burning, hives, and itching all through body that comes and goes. Could this be delayed reaction to vaccine? highly concerned about getting 2nd vaccine.
patient passed out multiple times, 4 total.  Patient felt flush and sweaty when he came back.  Episode lasted about 30 minutes
Patient states, awakened with fever 102.8 the following morning after receiving vaccine. Myalgia, arthralgia and continued episodes of fever over 72 hours.
Complaint of nausea and vomited x1.  Dad stated, "he is nervous."    10:42 am medics activated.  Client complexion noted to be pink, he was alert and having conversation with dad.  Stated client he felt better.  10:46 am medics arrived, had conversation with dad.  Noted to be ambulatory, alert, exited.
Chest tightness, heaviness.  Paramedics assessed, and patient chose to return home.
Left arm swelling, redness, "sore" pain with skin warm to touch. Cephalexin 500mg (1 cap) 4 times per day for 7 days.
Didn´t received his second dose of shingrix after he received his first dose during 2018; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive his second dose of Shingrix which led to incomplete course of vaccination.
Tinnitus in left ear.  Started about 10 days after 1st dose. It's progressively getting worse. I received my 2nd dose on 3/17
Developed slight rash, no hives, no shortness of breath 20 minutes post vaccine.  Consult with primary care provider on site.  Oral Diphenhydramine 25 mg given orally.  Symptoms improved, discharged home.
Pt. stated left upper arm became red, swollen, painful and hot a few hours after Pneumonia vaccine given.  Also, had chills, body aches and fever of 100.2 that evening.  On 11/11, she felt slightly better, but arm still swollen, red and painful, but no fever, chills or body aches. Follow up phone call on 11/17, husband stated that she was completely recovered.
Severe headache; nausea; fever; chills; body aches; fatigue; This is a spontaneous report from a non-contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), via an unspecified route of administration (left arm) on 23Dec2020 (14:45) at single dose for Covid-19 immunization.  Medical history was reported as none.  The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe headache, nausea, fever, chills, body aches, and fatigue on 24Dec2020 (12:00AM). There was no treatment received for the adverse events. The outcome of events was recovering. The patient has not been tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
Narrative: 74 y/o M found to have low grade fevr (99.5f) on 1/4/21 at 19:48 likely attributed to COVID-19 vaccine administration on 1/4/21 at 13:10. Veteran was given APAP650mg on 1/4/21 at 19:29, 21:26 and temperature resolved to 98.8.
pt has had production of white sputum since the flu vax was given, 2 wks ago;
Information has been received from a certified medical assistant concerning a now 36 year old female who on an unspecified date was vaccinated with a dose of MMR II (route, dose and lot# not reported) when she was younger. On an unspecified date the patient had titer done and did not have immunity. Additional information has been requested.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment information was provided.
Patient came by the clinic stated was vaccinated last 06/16/2005 in our clinic with TD and MMR.  After June 21 in the evening complained of not feeling good stated was shaking whole body and was with high temperature and did not have a chance to check temperature that night.  06/22/2005 patient stated her body was sore and there was weakness and patient checked temperature was 102 degrees.  06/24/2005 and 06/25/2005 patient stated temperature went up to 103 degrees.  06/26/2005 rechecked temperature was 104 degrees, patient called urgent care and talked to the nurse about her situation and the nurse advised patient to take meds for fever and patient took 500 mg of Tylenol extra strength and also advil 200 mg.  Patient stated that whole day was burning up and broke out in lots of sweating.  Today 06/7/2005 rechecked her temperature at clinic 101.9 degrees with lots of rashes on her face only, nothing on her body and legs and arms.  Patient states today feeling lot better and temperature down.  Advised patient to see doctor if more problems occur.
103 fever day following shot, sick for 2 days after that. 3rd day severe abdominal pain, threw up bile, diarrhea, effects lasted 7 hours, then it was mild stomach pain for a few days. No treatment.   August 13 had another episode of severe abdominal pain, throwing up bile, diarrhea, and effects lasted 7 hours with mild stomach pain for a few days. Went to an urgent care, but they wouldn?t see me and said I needed to go to the ER. By the time we got to the ER the pain had subsided (it had been 7 hours) and just went home instead.   September 15th had another episode with the same symptoms again lasting 7 hours. Went to doctor but she was unable to give a diagnosis and does not know what the issue might be. While there I had an ultrasound done on my gall bladder, intestines, and pancreas, but everything looked normal.
patient was scheduled to get the second dose however they had travelled so they cannot get their second dose; tested positive for covid-19; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient was scheduled to get the second dose however they had travelled so they cannot get their second dose), SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and MYALGIA (arm pain) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced MYALGIA (arm pain). On 03-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT DOSE OMISSION ISSUE (patient was scheduled to get the second dose however they had travelled so they cannot get their second dose) and SARS-COV-2 TEST POSITIVE (tested positive for covid-19). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient was scheduled to get the second dose however they had travelled so they cannot get their second dose), SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and MYALGIA (arm pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2021, COVID-19: positive (Positive) The Patient tested Positive for COVID-19 on 03-May-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter. Patient have event like mild symptoms of COVID-19.
arm was swollen to the point he could not put on a shirt; This case was reported by a physician via call center representative and described the occurrence of swelling in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced swelling. The patient was treated with prednisone. On an unknown date, the outcome of the swelling was unknown.   It was unknown if the reporter considered the swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and experienced unusual reaction to Shingrix described as the patient's arm was swollen to the point he could not put on a shirt. It was reported that no lymph swelling and worried if patient is administered prednisone that it would inactivate Shingrix vaccine. The reporter consented to follow up.
Information has been received from a physician concerning an 18 year old female was vaccinated with a dose of Gardasil. Concomitant therapy included four other vaccines (therapy unspecified). The physician reported that the patient passed out after receiving the dose of Gardasil. Unspecified medical attention was sought by the patient. the outcome was unknown. Additional information has been requested.
Patient  received her 2nd dose of Pfizer Covid-19 vaccine, Lot #EN6199, in her left deltoid on 3/11/2021 at approximately 9:24am. Patient disclosed to nurse and medic at vaccination clinic that she had allergies to peanuts and eggs and would need to wait in the parking lot longer than usual. Nurse and medic confirmed this and advised she wait a minimum of 30 mins but longer if she felt necessary. While waiting in the parking lot, at approximately 10:25am, patient began to have shortness of breath and made the medics aware. Patient also had facial redness and nausea. Medics administered 50mg of Benadryl , 0.3ml Epinephrine, and started IV with IV fluids. Patient was transported to Medical Center.
Initial report received on 03 April 2009 from a health professional. A female patient, whose age and medical history were not reported, received Fluzone (lot number not reported) on an unspecified date and developed "leg problems". The patient was seen by a neurologist. At the time of the report, no other details were known.
Vaccines given 9/23/08 at approximately 3:30 p.m.  On 9/24/08 client reports patient had a fever 105 degrees at 6:30 a.m. and taken to Hospital. Was discharged from hospital same day when fever was reduced with Tylenol and Motrin.  Client states patient will follow up with Dr today and is still having a fever of 103 degrees.
See started having shortness of breath on the night of 8/2/2021. He sends her to do tests, and she was taken to the hospital. She died in the hospital due to kidney and heart failure.
second one was sore; This case was reported by a consumer via media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain (1st dose received on unknown date and experienced pain, for further tolerance refer case US2021AMR127114).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported.  The patient received 2nd dose of Shingles vaccine and experienced sore. The patient also had the second one which was sore but not both and one day it's good to get single shot as it helped keep itching bumps and everything away and feel fine. The reporter reported that some people can take the shingles shot some people cannot like him/her for instance it was all right for him/her. The follow up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR127114:Same reporter
Rec'd AFLURIA IM left deltoid on 10-8-13. Reported tenderness, erythema and bump took ALEVE x 1. 10-11-13 pt reports resolved.
Small eczema like rash near elbow.  Mildly itchy but relieved with ointment (Aquaphor). Lasted 3-4 days
severe coughing; Fever two days 101; chills; body pain; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). A 62-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 16Oct2021 at 14:00 (at the age of 62 years old), as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunization. The patient was not pregnant at time of vaccination. The patient medical history was not reported. The patient had no known allergies. Concomitant medication(s) included Amiloride, Phentermine and acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN [ACETYLSALICYLIC ACID; CAFFEINE; PARACETAMOL]), all taken for an unspecified indication, start and stop date were not reported. Historical vaccine the patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 20Feb2021 (at the age of 62-year-old), as dose 1,single and patient also received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 13Mar2021(at the age of 62-year-old), as dose 2, single for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. On 16Oct2021 at 20:00, the patient experienced severe coughing, fever two days 101, chills and body pain. The patient underwent lab tests which included body temperature: 101 on 16Oct2021. No treatment was received to treat the events. The outcome of the events was resolving at the time of this report.  Information about lot/batch number cannot be obtained. No further information expected.
Information has been received from a physician concerning a female (age not reported) who on an unspecified date was vaccinated with a first dose of GARDASIL (lot# unknown). In June 2007, the patient was vaccinated with a second dose of GARDASIL. The patient developed "dermatitis all down her arm" right after getting her second dose. Medical attention was sought. At the time of reporting it is unknown if the patient had recovered. No further information was provided. Additional information has been requested. This is in follow-up to report(s) previously submitted on 8/14/2007. Follow-up information was received. On 21-DEC-2006 the patient was vaccinated with a second dose of GARDASIL (lot #653735/0688F). On the same day the patient developed a mild red maculopapular eruption on the injection site arm. On an unspecified date the patient recovered approximately one week after injection. On 25-MAY-2007 the patient was vaccinated with a third dose of GARDASIL (lot# 657737/0522U) IM in the right deltoid. On an unspecified date the patient developed a much worse maculopapular rash on the injected extremity and trunk on that side. On an unspecified date the patient recovered without therapy. Additional information is not expected.